This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse our events, training, articles and people by topicclose

Popular sectors

A - Z

Browse Topicsappsclose
search

Cell & Gene Therapy

Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Events

Showing 6 of 9 eventsView all events
Featured

Cell & Gene Therapy Manufacturing & Commercialization Asia

April 11-14, 2022, Presented in Japan Standard Time (JST)

The ONLY Cell and Gene Therapy event in Asia to help you fast track manufacturing & commercialization across borders

Featured

Next Generation CAR & T Cell Therapies

June 14-16, 2022, San Francisco, California

CAR AND T CELL THERAPIES: IMPROVE THE SAFETY & EFFICACY OF YOUR NOVEL CAR MODALITIES THROUGH TRANSLATIONAL SCIENCE AND CUTTING EDGE CLINICAL DATA

Cell & Gene Therapy Manufacturing & Commercialization Europe

29 November - 9 December, 2021

THE EUROPEAN CELL AND GENE THERAPY CONGRESS FOR GROUND BREAKING MANUFACTURING, COMMERCIALISATION & SUPPLY CHAIN STRATEGIES

mRNA Applications in Discovery & Development

November 30 - December 2, Delivered in Eastern Standard Time (EST)

Industry Leaders & Service Providers will showcase the power and diversity of mRNA technologies and applications across discovery, R&D, manufacturing & delivery

Cell & Gene Therapy Manufacturing & Commercialization US

Mark Your Calendar for Next Year's Event!, Boston Convention and Exhibition Center

The Cell, Gene & Immunotherapy Event for Ground-Breaking Bioprocessing, Manufacturing and Supply Chain Strategies

Applications of Gene Editing

November 2-5, 2020, in Pacific Standard Time (PST)

Precise, efficient & safer genome editing – changing the face of genetic disorders and rare disease

Training

Showing 4 of 4 courses

Viral Vectors in Cell & Gene Therapy

TBC, 5 sessions delivered over 2 weeks

Understand why viral vectors are used in cell and gene therapy and explore how to choose the most appropriate vector for your product

Introduction to Cell & Gene Therapies

TBC, 5 sessions delivered over 2 weeks

Gain a thorough understanding of cell and gene therapies on this introductory course

Manufacturing Practices for Cell & Gene Therapies

2021 Dates TBC, 5 sessions delivered over 5 days

Understand key manufacturing principles for Cell, Gene-Modified Cell and Gene Therapies

Regulatory, Developmental And Manufacturing Challenges For Cell & Gene Therapies

November 2021, Delivered over 2 days

Acquire a practical understanding of the regulatory challenges, manufacturing concerns and clinical trial preparation for CGTs/ATMPs

Articles & Video

Showing 9 of 116 articles & videoView all articles & video
Featured
COVID-19

REPORT: COVID-19 Response in Cell & Gene Therapy Manufacturing 2021

This exclusive report uncovers the major changes in the cell and gene therapy sector during the COVID-19 pandemic.

Featured
Commercialization

Commercialization of Cell & Gene Therapies

This ebook presents insights from industry leaders, including partnering strategies, process technologies and control considerations.

Analytical methods

Novel analytical strategies and tools for cell and gene therapies - WHITEPAPER

What analytical techniques can be applied to production of cell therapies, gene therapies and gene-edited cell-therapies? This whitepaper looks at the latest examples.

Allogeneic

Allogeneic and Autologous Cell Therapies Survey 2021

What pitfalls come with each product type in cell therapy manufacturing and how can they be alleviated? We want to hear from you!

Cell & gene therapy

COVID hit cell and gene therapy trials and suppliers but experts see signs of recovery

Cell and gene therapy

Cell & Gene Therapy Manufacturing & Commercialization US Post Event Report

COVID-19

REPORT: COVID-19 One Year On - Impacts on the Global Life Sciences Industry 2021

Biotech investment

COVID-19 has benefited investment in the cell and gene therapy sector, say 78% of industry professionals

COVID-19

Life Sciences Survey: COVID-19 Impacts One Year On

SPONSORSHIP & EXHIBITION OPPORTUNITIES

There are many ways for your organisation to engage a qualified audience of 31,000+ cell therapy executives and scientists, including 1,800+ annual attendees gathered across the globe! Share your strategy and plans so we can help you identify the best opportunities to reach your objectives. Our team will collaborate with you to develop a bespoke program tailored to your unique needs.

To find out more, contact Luke Pickering, Account Director:
luke.pickering@informa.com | +44.(0)20.3377.3553

All opportunities can be customised to align with your needs and budget. Examples may include:

  • Exhibition space
  • Speaking slots and onsite video interviews
  • High-impact branding and messaging
  • Private/public hosted events (lunches, breakfasts, and receptions)
  • Custom digital campaigns
DOWNLOAD 2020 SPONSOR PROSPECTUS

Copyright © 2021 Informa Connect Limited. Registered in England & Wales with number 01835199, registered office 5 Howick Place, London, SW1P 1WG.